hydrogen has been researched along with Glioblastoma in 13 studies
Hydrogen: The first chemical element in the periodic table with atomic symbol H, and atomic number 1. Protium (atomic weight 1) is by far the most common hydrogen isotope. Hydrogen also exists as the stable isotope DEUTERIUM (atomic weight 2) and the radioactive isotope TRITIUM (atomic weight 3). Hydrogen forms into a diatomic molecule at room temperature and appears as a highly flammable colorless and odorless gas.
dihydrogen : An elemental molecule consisting of two hydrogens joined by a single bond.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myoinositol (MI) is an organic osmolyte, with intracellular concentration changes depending on the extracellular osmolality." | 5.43 | Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. ( Bähr, O; Hattingen, E; Pilatus, U; Ronellenfitsch, MW; Steidl, E; Steinbach, JP; Zanella, F, 2016) |
| "Previous ex vivo spectroscopic data from tissue samples revealed differences in phospholipid metabolites between isocitrate dehydrogenase mutated (IDHmut) and IDH wildtype (IDHwt) gliomas." | 3.91 | In vivo Metabolic Profiles as Determined by ( Bähr, O; Franz, K; Hattingen, E; Pilatus, U; Steinbach, J; Wenger, KJ, 2019) |
| "Myoinositol (MI) is an organic osmolyte, with intracellular concentration changes depending on the extracellular osmolality." | 1.43 | Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. ( Bähr, O; Hattingen, E; Pilatus, U; Ronellenfitsch, MW; Steidl, E; Steinbach, JP; Zanella, F, 2016) |
| "Two biopsies from glioblastomas are directly studied by (1)H-NMR without any treatment (ex vivo NMR)." | 1.31 | Characterization of lipids from human brain tissues by multinuclear magnetic resonance spectroscopy. ( Bottura, G; Fini, G; Tinti, A; Tosi, MR; Trinchero, A; Tugnoli, V, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wenger, KJ | 1 |
| Hattingen, E | 2 |
| Franz, K | 1 |
| Steinbach, J | 1 |
| Bähr, O | 2 |
| Pilatus, U | 2 |
| Liu, MY | 1 |
| Xie, F | 1 |
| Zhang, Y | 1 |
| Wang, TT | 1 |
| Ma, SN | 1 |
| Zhao, PX | 1 |
| Zhang, X | 1 |
| Lebaron, TW | 1 |
| Yan, XL | 1 |
| Ma, XM | 1 |
| Steidl, E | 1 |
| Steinbach, JP | 1 |
| Zanella, F | 1 |
| Ronellenfitsch, MW | 1 |
| Fortuniak, J | 1 |
| Jaskólski, DJ | 1 |
| Stefańczyk, L | 1 |
| Zawirski, M | 1 |
| Gajewicz, W | 1 |
| Magalhaes, A | 1 |
| Godfrey, W | 1 |
| Shen, Y | 1 |
| Hu, J | 1 |
| Smith, W | 1 |
| Timonen, M | 1 |
| Kankaanranta, L | 1 |
| Lundbom, N | 2 |
| Collan, J | 1 |
| Kangasmäki, A | 1 |
| Kortesniemi, M | 1 |
| Häkkinen, AM | 2 |
| Lönngren, A | 1 |
| Karjalainen, S | 1 |
| Rasilainen, M | 1 |
| Leinonen, J | 1 |
| Huitti, T | 1 |
| Jääskeläinen, J | 1 |
| Kouri, M | 1 |
| Savolainen, S | 1 |
| Heikkinen, S | 1 |
| Pulkkinen, J | 1 |
| Paetau, A | 1 |
| Kauppinen, RA | 1 |
| Hiltunen, Y | 1 |
| Hollingworth, W | 1 |
| Medina, LS | 1 |
| Lenkinski, RE | 1 |
| Shibata, DK | 1 |
| Bernal, B | 1 |
| Zurakowski, D | 1 |
| Comstock, B | 1 |
| Jarvik, JG | 1 |
| Hagberg, G | 2 |
| Burlina, AP | 1 |
| Mader, I | 2 |
| Roser, W | 2 |
| Radue, EW | 2 |
| Seelig, J | 2 |
| Wald, LL | 1 |
| Nelson, SJ | 1 |
| Day, MR | 1 |
| Noworolski, SE | 1 |
| Henry, RG | 1 |
| Huhn, SL | 1 |
| Chang, S | 1 |
| Prados, MD | 1 |
| Sneed, PK | 1 |
| Larson, DA | 1 |
| Wara, WM | 1 |
| McDermott, M | 1 |
| Dillon, WP | 1 |
| Gutin, PH | 1 |
| Vigneron, DB | 1 |
| Dellas, S | 1 |
| Steinbrich, W | 1 |
| Tugnoli, V | 1 |
| Tosi, MR | 1 |
| Tinti, A | 1 |
| Trinchero, A | 1 |
| Bottura, G | 1 |
| Fini, G | 1 |
| Tarnawski, R | 1 |
| Sokol, M | 1 |
| Pieniazek, P | 1 |
| Maciejewski, B | 1 |
| Walecki, J | 1 |
| Miszczyk, L | 1 |
| Krupska, T | 1 |
1 review available for hydrogen and Glioblastoma
| Article | Year |
|---|---|
A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors.
Topics: Astrocytoma; Brain Neoplasms; Diagnosis, Differential; Glioblastoma; Humans; Hydrogen; Magnetic Reso | 2006 |
12 other studies available for hydrogen and Glioblastoma
| Article | Year |
|---|---|
In vivo Metabolic Profiles as Determined by
Topics: Adult; Aged; Analysis of Variance; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Diagnosis, Diffe | 2019 |
Molecular hydrogen suppresses glioblastoma growth via inducing the glioma stem-like cell differentiation.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Self Renewa | 2019 |
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Biomarkers, Tumor; Brain N | 2016 |
Magnetic resonance imaging of rare intracranial neoplasms--role of the in vivo 1 h spectroscopy in the radiological differential diagnostics.
Topics: Adult; Brain Chemistry; Brain Neoplasms; Chondroma; Choroid Plexus Neoplasms; Diagnosis, Differentia | 2010 |
Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatin | 2005 |
1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
Topics: Adult; Aged; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carcinoma; Fema | 2005 |
Independent component analysis to proton spectroscopic imaging data of human brain tumours.
Topics: Algorithms; Aspartic Acid; Astrocytoma; Brain Neoplasms; Cell Proliferation; Choline; Creatine; Glio | 2005 |
In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.
Topics: Adult; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Cluster Analysis; Creatine; Discriminan | 1995 |
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
Topics: Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Disease Pro | 1997 |
Assignment of glial brain tumors in humans by in vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification.
Topics: Astrocytoma; Biopsy; Brain Neoplasms; Glioblastoma; Glioma; Humans; Hydrogen; Magnetic Resonance Spe | 1997 |
Characterization of lipids from human brain tissues by multinuclear magnetic resonance spectroscopy.
Topics: Brain Chemistry; Brain Neoplasms; Carbon Isotopes; Cholesterol; Cholesterol Esters; Glioblastoma; Hu | 2001 |
1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas.
Topics: Adult; Aged; Brain Neoplasms; Glioblastoma; Glioma; Humans; Hydrogen; Magnetic Resonance Spectroscop | 2002 |